Clinical practice guidelines by the American College of Chest Physicians guide management.
The<unk>  approach to deep vein thrombosis (DVT) depends on the location of DVT and the presence or absence of contraindications to anticoagulation.  In the absence of any contraindication to anticoagulation therapy, the<unk>  of DVT with parental anticoagulant should be initiated in case of intermediate or high suspicion of DVT even before the diagnostic confirmatory tests are complete.  The choice of parental anticoagulation include: low molecular weight heparin (LMWH), fondaparinux, IV unfractionated heparin (UFH), and SC-UFH; however, the administration of LMWH (once daily rather than twice daily) and fondaparinux is recommended over IV-UFH and SCUFH.  Parental anticoagulation therapy should be administered for at least 5 days and until the INR is equal or more than 2 for more than 24 hours.
Deep vein thrombosis treatment approach
Deep vein thrombosis invasive therapy
Stent thrombosis treatment
Deep vein thrombosis medical therapy
Stent thrombosis prevention
Deep vein thrombosis cost-effectiveness of therapy
Deep vein thrombosis diagnostic approach
Deep vein thrombosis future or investigational therapies